Larimar Therapeutics Files 8-K
Ticker: LRMR · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1374690
| Field | Detail |
|---|---|
| Company | Larimar Therapeutics, Inc. (LRMR) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, pharmaceutical
Related Tickers: LRMR
TL;DR
Larimar Therapeutics (LRMR) filed an 8-K on 6/23/25. Standard reporting.
AI Summary
Larimar Therapeutics, Inc. filed an 8-K on June 23, 2025, reporting other events and financial statements. The company, formerly known as Zafgen, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations industry. Its principal executive offices are located in Bala Cynwyd, Pennsylvania.
Why It Matters
This filing indicates routine corporate reporting, providing updates on events and financial information for Larimar Therapeutics, Inc.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain significant new material events.
Key Players & Entities
- Larimar Therapeutics, Inc. (company) — Registrant
- Zafgen, Inc. (company) — Former company name
- June 23, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Bala Cynwyd, Pennsylvania (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Larimar Therapeutics, Inc.?
The filing is a Current Report on Form 8-K, reporting 'Other Events' and 'Financial Statements and Exhibits' as of June 23, 2025.
When was the earliest event reported in this filing?
The earliest event reported is dated June 23, 2025.
What was Larimar Therapeutics, Inc. formerly known as?
Larimar Therapeutics, Inc. was formerly known as Zafgen, Inc.
In which state is Larimar Therapeutics, Inc. incorporated?
Larimar Therapeutics, Inc. is incorporated in Delaware.
What is the business address of Larimar Therapeutics, Inc.?
The business address is Three Bala Plaza East, Suite 506, Bala Cynwyd, Pennsylvania, 19004.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 regarding Larimar Therapeutics, Inc. (LRMR).